BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21329968)

  • 1. Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus.
    Cakebread JA; Xu Y; Grainge C; Kehagia V; Howarth PH; Holgate ST; Davies DE
    J Allergy Clin Immunol; 2011 May; 127(5):1148-54.e9. PubMed ID: 21329968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.
    Wark PA; Johnston SL; Bucchieri F; Powell R; Puddicombe S; Laza-Stanca V; Holgate ST; Davies DE
    J Exp Med; 2005 Mar; 201(6):937-47. PubMed ID: 15781584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells.
    Vareille M; Kieninger E; Alves MP; Kopf BS; Möller A; Geiser T; Johnston SL; Edwards MR; Regamey N
    Thorax; 2012 Jun; 67(6):517-25. PubMed ID: 22213737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR3 and MDA5 signalling, although not expression, is impaired in asthmatic epithelial cells in response to rhinovirus infection.
    Parsons KS; Hsu AC; Wark PA
    Clin Exp Allergy; 2014 Jan; 44(1):91-101. PubMed ID: 24131248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exogenous interferons on rhinovirus replication and airway inflammatory responses.
    Becker TM; Durrani SR; Bochkov YA; Devries MK; Rajamanickam V; Jackson DJ
    Ann Allergy Asthma Immunol; 2013 Nov; 111(5):397-401. PubMed ID: 24125148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of bronchial fibroblasts to the antiviral response in asthma.
    Bedke N; Haitchi HM; Xatzipsalti M; Holgate ST; Davies DE
    J Immunol; 2009 Mar; 182(6):3660-7. PubMed ID: 19265144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD.
    Baines KJ; Hsu AC; Tooze M; Gunawardhana LP; Gibson PG; Wark PA
    Respir Res; 2013 Feb; 14(1):15. PubMed ID: 23384071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma.
    Baraldo S; Contoli M; Bazzan E; Turato G; Padovani A; Marku B; Calabrese F; Caramori G; Ballarin A; Snijders D; Barbato A; Saetta M; Papi A
    J Allergy Clin Immunol; 2012 Dec; 130(6):1307-14. PubMed ID: 22981791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in the bronchial epithelial cell response to infection with different rhinovirus strains.
    Wark PA; Grissell T; Davies B; See H; Gibson PG
    Respirology; 2009 Mar; 14(2):180-6. PubMed ID: 19207121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium.
    Porter JD; Watson J; Roberts LR; Gill SK; Groves H; Dhariwal J; Almond MH; Wong E; Walton RP; Jones LH; Tregoning J; Kilty I; Johnston SL; Edwards MR
    J Antimicrob Chemother; 2016 Oct; 71(10):2767-81. PubMed ID: 27494903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th2-type cytokine-induced mucus metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection.
    Jakiela B; Gielicz A; Plutecka H; Hubalewska-Mazgaj M; Mastalerz L; Bochenek G; Soja J; Januszek R; Aab A; Musial J; Akdis M; Akdis CA; Sanak M
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):229-41. PubMed ID: 24588727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations.
    Wark PA; Bucchieri F; Johnston SL; Gibson PG; Hamilton L; Mimica J; Zummo G; Holgate ST; Attia J; Thakkinstian A; Davies DE
    J Allergy Clin Immunol; 2007 Sep; 120(3):586-93. PubMed ID: 17628646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication.
    Marcellini A; Swieboda D; Guedán A; Farrow SN; Casolari P; Contoli M; Johnston SL; Papi A; Solari R
    Eur J Pharmacol; 2021 Feb; 893():173839. PubMed ID: 33359650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta promotes rhinovirus replication in bronchial epithelial cells by suppressing the innate immune response.
    Bedke N; Sammut D; Green B; Kehagia V; Dennison P; Jenkins G; Tatler A; Howarth PH; Holgate ST; Davies DE
    PLoS One; 2012; 7(9):e44580. PubMed ID: 22970254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons.
    Gielen V; Sykes A; Zhu J; Chan B; Macintyre J; Regamey N; Kieninger E; Gupta A; Shoemark A; Bossley C; Davies J; Saglani S; Walker P; Nicholson SE; Dalpke AH; Kon OM; Bush A; Johnston SL; Edwards MR
    J Allergy Clin Immunol; 2015 Jul; 136(1):177-188.e11. PubMed ID: 25630941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects.
    Lopez-Souza N; Favoreto S; Wong H; Ward T; Yagi S; Schnurr D; Finkbeiner WE; Dolganov GM; Widdicombe JH; Boushey HA; Avila PC
    J Allergy Clin Immunol; 2009 Jun; 123(6):1384-90.e2. PubMed ID: 19428098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhinovirus 16-induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients.
    Sykes A; Edwards MR; Macintyre J; del Rosario A; Bakhsoliani E; Trujillo-Torralbo MB; Kon OM; Mallia P; McHale M; Johnston SL
    J Allergy Clin Immunol; 2012 Jun; 129(6):1506-1514.e6. PubMed ID: 22657407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-β induces a long-lasting antiviral state in human respiratory epithelial cells.
    Gaajetaan GR; Geelen TH; Vernooy JH; Dentener MA; Reynaert NL; Rohde GG; Beuken EV; Grauls GE; Bruggeman CA; Stassen FR
    J Infect; 2013 Feb; 66(2):163-9. PubMed ID: 23201152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Pim1 kinase, new therapeutic approach in virus-induced asthma exacerbations.
    Vries Md; Bedke N; Smithers NP; Loxham M; Howarth PH; Nawijn MC; Davies DE
    Eur Respir J; 2016 Mar; 47(3):783-91. PubMed ID: 26869670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin induces anti-viral responses in bronchial epithelial cells.
    Gielen V; Johnston SL; Edwards MR
    Eur Respir J; 2010 Sep; 36(3):646-54. PubMed ID: 20150207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.